PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia cover art

PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia

PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia

Listen for free

View show details

About this listen

 This podcast explores macular telangiectasia (MacTel), a rare and progressive retinal disease, with a focus on advancing early detection, appropriate treatment, and health system coordination. Retina specialist Dr. Jay Chhablani discusses the shift in understanding MacTel as a neurodegenerative—not vascular—condition, highlighting the limitations of anti-VEGF therapy and the significance of a newly approved, durable implant that targets neuroprotection. The discussion outlines the importance of benefit design that facilitates timely access, supports multidisciplinary care, and emphasizes early intervention to prevent irreversible vision loss. Practical payer strategies—including reducing artificial barriers and prioritizing education—are addressed to optimize outcomes. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mactel-strategies-ce/.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.